Sec Form 13G Filing - Domain Partners VIII L.P. filing for Bionano Genomics Inc. (BNGO) - 2021-01-20

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

_____________________

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

(Amendment No. 1)¹

Check the appropriate box to designate the rule pursuant to which this Schedule is Filed:

[   ] Rule 13d-1(b)

[   ] Rule 13d-1(c)

[X] Rule 13d-1(d)

_______________________

¹The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.  The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.

CUSIP No. 09075F107

CUSIP No. 09075F107

1)	Name of Reporting Person I.R.S. Identification No. of Above Person (Entities Only) (Voluntary)   DP VIII Associates, L.P.
2)	Check the Appropriate Box if a Member of a Group				(a)  [X] (b) [   ]
3)	SEC Use Only
4)	Citizenship or Place of Organization			Delaware
Number of Shares Beneficially Owned by Each Reporting Person With		5)	Sole Voting Power			-0-
		6)	Shared Voting Power			-0-
		7)	Sole Dispositive Power			-0-
		8)	Shared Dispositive Power			-0-
9)	Aggregate Amount Beneficially Owned by Each Reporting Person				-0-
10)	Check if the Aggregate Amount in Row (9) Excludes Certain Shares   [   ]
11)	Percent of Class Represented by Amount in Row (9)				-0-
12)	Type of Reporting Person				PN

CUSIP No. 09075F107

Reference is hereby made to the statement on Schedule 13G filed with the Securities and Exchange Commission by the Reporting Persons with respect to the Common Stock of the Issuer on January 11, 2019 (the “Schedule 13G”).  Terms defined in the Schedule 13G are used herein as so defined.

The following items of the Schedule 13G are hereby amended and restated as follows:

Item 4  –  Ownership.

(a) through (c):

The information requested in these paragraphs is incorporated herein by reference to the cover pages to this Amendment No. 1 to Schedule 13G.  In addition, as of December 31, 2020, Domain Associates, L.L.C., an affiliate and the investment manager of the Reporting Persons, directly beneficially owned 140 shares of Common Stock, or less than 0.1% of the Common Stock outstanding.

Item 5  –  Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that the Reporting Persons have ceased to be the beneficial owners of more than five percent of the Common Stock, check the following:  [X]

CUSIP No. 09075F107

After reasonable inquiry and to the best of their knowledge and belief, the undersigned hereby certify that the information set forth in this statement is true, complete and correct.

Dated:  January 20, 2021